Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$20.20
Based on 0.6% avg growth
INTRINSIC VALUE TODAY
$12.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
Valuation Analysis: M is currently trading at $18.31, which is considered oversold relative to its 30-day fair value range of $18.62 to $19.87. The stock's valuation (Forward PE: 8.6) is in line with its historical norms (9.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This pessimistic expectation contrasts with the company's recent 52.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, M is in a strong downtrend. The price is currently testing key support at $17.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.62 -
$19.87
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($19.40)
Trading Range Analysis
30-Day Trading Range
$18.62 -
$19.87
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level$17.99
Resistance Level$20.10
Current TrendStrong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)8.56
Wall Street Target
$19.40
(+6.0%)
Revenue Growth (YoY)-1.1%
Earnings Growth (YoY)52.0%
Profit Margin2.8%
Valuation Discount vs History
-2.3% cheaper
PE vs Historical
8.6 vs 9.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):-2.3%
(market-implied from PE analysis)
1-Year Target
$17.89
(-2%)
2-Year Target
$17.48
(-5%)
3-Year Target
$17.08
(-7%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
$18.36
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: -2.9%)
$43.17
(+136%)
Base:
(SPY PE: 8.6, Growth: -2.9%)
$16.76
(-8%)
Bear:
(PE: 7.3, Growth: -2.9%)
$14.25
(-22%)
📈Valuation based on Current Earnings
Trailing PE: 7.94 | Current EPS (TTM): $2.32
Bull Case
$18.70
(+2%)
Analyst growth -7.8%, PE expands to 8.7
Base Case
$17.00
(-7%)
Market implied -7.8%, PE stable at 7.9
Bear Case
$12.53
(-32%)
Severe decline -20.0%, PE contracts to 6.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.6 to 9.2
Stabilization Target:
$19.68
(+7.5%)
PE Expansion Potential:
+7.5%
Share & Embed Analysis
Found this analysis useful? Share it with your community or embed the live chart on your blog.
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.